ArticleBMC plant biology2026
The effect of foliar chitosan application on fusarium head blight in barley is highly genotype dependent.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFusarium head blight (FHB) is a severe disease of barley that reduces yield and grain quality through contamination with mycotoxins. Conventional disease management provides only partial control under field conditions. Elicitors such as chitosan, a natural biopolymer, are promising alternatives to enhance plant resistance, but the efficacy of induced resistance may depend on host genotype and environmental conditions.
resultsWe investigated the effect of chitosan on FHB resistance in 39 diverse spring barley genotypes inoculated with Fusarium culmorum. Greenhouse experiments revealed reduced FHB severity and fungal DNA contents in several genotypes following chitosan pre-treatment and strong genotype-dependent effects. Field experiments at two locations indicated that chitosan treatment can reduce FHB severity under natural infection conditions, though the effects varied depending on genotype and environment. The cultivar Marthe consistently showed enhanced resistance across independent experiments. In addition, Chitosan pre-treatment induced ethylene production in barley leaves, suggesting activation of stress-related signalling pathways. However, ethylene release was attenuated after a second chitosan exposure, indicating a modulation of stress responses. Gene expression analysis of defence-related and Fusarium-responsive genes indicated a mitigated stress response in chitosan-induced barley. This may reflect reduced fungal success and suggests that chitosan induction of resistance might result in a physiologically cost-efficient defence mechanism in barley.
conclusionsChitosan is a strong inducer of barley disease resistance with potential for integration into FHB management. Our results demonstrate that elicitor-induced resistance is a quantitative and genotype-dependent trait, and that cultivar-specific responses are likely transferable from controlled to field conditions. Identifying genotypes, such as Marthe, with consistent responsiveness to bioactive stimulants, offers breeding potential for optimised elicitor-induced resistance. This could support more sustainable FHB management strategies in barley in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.